Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3708998015 | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3708999011 | Carbidopa- and levodopa-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4625411000052112 | läkemedel som innehåller karbidopa och levodopa, oral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Is a | Product containing carbidopa and levodopa (medicinal product) | true | Inferred relationship | Some | ||
| Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Has active ingredient | Carbidopa | true | Inferred relationship | Some | 2 | |
| Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Has active ingredient | Levodopa (substance) | true | Inferred relationship | Some | 1 | |
| Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Is a | Product containing carbidopa in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Is a | Product containing levodopa in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| karbidopa 12,5 mg + levodopa 50 mg, tablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa 10 mg + levodopa 100 mg, tablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa 25 mg + levodopa 100 mg, tablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa 25 mg + levodopa 250 mg, tablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa 25 mg + levodopa 100 mg, tablett med modifierad frisättning | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa 10 mg + levodopa 100 mg, munsönderfallande tablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa 25 mg + levodopa 100 mg, munsönderfallande tablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa 25 mg + levodopa 250 mg, munsönderfallande tablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 100 milligram, depåtablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| karbidopa (som karbidopamonohydrat) 50 milligram och levodopa 200 milligram, depåtablett | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) | Is a | True | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing only carbidopa and levodopa in oral dose form (medicinal product form) | Is a | True | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR